Edeline, Julien http://orcid.org/0000-0002-8289-7741
Rolland, Yan
Campillo-Gimenez, Boris
Bourien, Héloïse
Trochet, Marion
Garin, Etienne
Boudjema, Karim
Funding for this research was provided by:
Boston Scientific Corporation
Institut National Du Cancer (PHRC-K 2020)
Article History
Received: 3 September 2022
Accepted: 11 October 2022
First Online: 21 October 2022
Disclosures
: Julien Edeline, Yan Rolland, and Etienne Garin report honoraria from Boston Scientific. Julien Edeline and Etienne Garin report research funding from Boston Scientific. Boris Campillo-Gimenez, Héloïse Bourien, Marion Trochet, and Karim Boudjema have no conflicts of interest to report.